Bessemer Group’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,000
| Closed | -$36K | – | 2083 |
|
|
2022
Q3 | $36K | Hold |
4,000
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q2 | $40K | Hold |
4,000
| – | – | ﹤0.01% | 1146 |
|
|
2022
Q1 | $46K | Hold |
4,000
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q4 | $44K | Hold |
4,000
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q3 | $37K | Hold |
4,000
| – | – | ﹤0.01% | 1117 |
|
|
2021
Q2 | $45K | Hold |
4,000
| – | – | ﹤0.01% | 1085 |
|
|
2021
Q1 | $42K | Hold |
4,000
| – | – | ﹤0.01% | 1043 |
|
|
2020
Q4 | $43K | Hold |
4,000
| – | – | ﹤0.01% | 1018 |
|
|
2020
Q3 | $39K | Sell |
4,000
-89,900
| -96% | -$877K | ﹤0.01% | 957 |
|
|
2020
Q2 | $747K | Hold |
93,900
| – | – | ﹤0.01% | 880 |
|
|
2020
Q1 | $816K | Hold |
93,900
| – | – | ﹤0.01% | 655 |
|
|
2019
Q4 | $1.06M | Sell |
93,900
-400
| -0.4% | -$4.52K | ﹤0.01% | 727 |
|
|
2019
Q3 | $1.03M | Buy |
94,300
+15,500
| +20% | +$168K | ﹤0.01% | 692 |
|
|
2019
Q2 | $738K | Sell |
78,800
-17,700
| -18% | -$166K | ﹤0.01% | 776 |
|
|
2019
Q1 | $1.19M | Buy |
96,500
+38,400
| +66% | +$472K | ﹤0.01% | 593 |
|
|
2018
Q4 | $688K | Buy |
58,100
+18,500
| +47% | +$219K | ﹤0.01% | 669 |
|
|
2018
Q3 | $570K | Buy |
39,600
+16,700
| +73% | +$240K | ﹤0.01% | 731 |
|
|
2018
Q2 | $341K | Buy |
22,900
+5,400
| +31% | +$80.4K | ﹤0.01% | 871 |
|
|
2018
Q1 | $228K | Hold |
17,500
| – | – | ﹤0.01% | 988 |
|
|
2017
Q4 | $221K | Hold |
17,500
| – | – | ﹤0.01% | 1002 |
|
|
2017
Q3 | $227K | Hold |
17,500
| – | – | ﹤0.01% | 1035 |
|
|
2017
Q2 | $260K | Buy |
+17,500
| New | +$260K | ﹤0.01% | 1007 |
|
|
2013
Q4 | – | Sell |
-44,226
| Closed | -$540K | – | 1371 |
|
|
2013
Q3 | $540K | Sell |
44,226
-86,064
| -66% | -$1.05M | ﹤0.01% | 528 |
|
|
2013
Q2 | $1.72M | Buy |
+130,290
| New | +$1.72M | 0.02% | 315 |
|